[1]
“Prognostic Value of Baseline and Post-Treatment Hemoglobin Levels in Head and Neck Squamous Cell Carcinoma: Insights from a Multi-Center Cohort Study”, JOC, vol. 24, no. 7s, pp. 222–231, Sep. 2025, doi: 10.64149/J.Carcinog.24.7s.222-231.